Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Kazutaka Nishimura"'
Autor:
Tomotaka Tanaka, Hiroshi Yamagami, Masafumi Ihara, Rie Motoyama, Kazuki Fukuma, Tetsuya Miyagi, Kazutaka Nishimura, Kazunori Toyoda, Kazuyuki Nagatsuka
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136200 (2015)
Seizure is a common complication after stroke (termed "post-stroke seizure," PSS). Although many studies have assessed outcomes and risk factors of PSS, no reliable predictors are currently available to determine PSS recurrence. We compared baseline
Externí odkaz:
https://doaj.org/article/cdacfe130fff4243871dc7cc5b86de30
Autor:
Ryohei Ono, Kazutaka Nishimura, Hidehisa Takahashi, Yasuhiko Hori, Kenichi Fukushima, Yoshio Kobayashi
Publikováno v:
Drugs in R&D. 22:281-288
Chromogenic anti-factor Xa activity (AXA) assay is used to measure the pharmacodynamics of factor Xa inhibitors, including edoxaban. Although AXA concentrations in patients with non-valvular atrial fibrillation using edoxaban have been reported, the
Autor:
Daichi Yamashita, Hidehisa Takahashi, Yasuhiko Hori, Ryohei Ono, Tatsuro Yamazaki, Kenichi Fukushima, Kazutaka Nishimura
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 395:159-166
Apixaban is used to treat venous thromboembolism (VTE) at 10 mg twice daily (BID) for 7 days, followed by 5 mg BID without dose adjustment, and non-valvular atrial fibrillation (NVAF) at 5 mg BID or 2.5 mg BID with dose adjustment criteria (DAC) incl
Publikováno v:
Japanese Journal of Stroke. 42:80-83
Autor:
Takeshi Fukushima, Masayuki Saijo, Hiroe Fuse, Kazuo Nakamichi, Kazutaka Nishimura, Yuta Iwai, Satoshi Kuwabara, Mariko Yabuki, Kenta Takahashi, Tadaki Suzuki
Publikováno v:
Clinical and Experimental Neuroimmunology. 12:63-65
Autor:
Junjiro Kobayashi, Kazuo Minematsu, Kazuyuki Nagatsuka, Masatoshi Koga, Kazunori Toyoda, Kazutaka Nishimura, Jun Takahashi
Publikováno v:
Journal of the Neurological Sciences. 363:195-199
Backgrounds Although prevention of hematoma enlargement and thromboembolic complications is critically important in acute intracerebral hemorrhage (ICH) patients with prosthetic heart valves, clinical data are scarce. The goal of this study was to el
Autor:
Satoshi Kuwabara, Yuya Aotsuka, Mika Yamaguchi, Takahiro Makino, Akiyuki Uzawa, Kazuo Nakamichi, Kazutaka Nishimura, Kazuho Kojima, Masayuki Saijo
Publikováno v:
Internal Medicine. 55:1645-1647
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease that favors the cerebrum and typically occurs in immunosuppressed patients. We herein report the case of a 66-year-old man with PML, idiopathic CD4(+) T lymphocytopenia (ICL)
Autor:
Chiaki Yokota, Kazutaka Nishimura
Publikováno v:
Nihon Naika Gakkai Zasshi. 103:1791-1797
Autor:
Toshihisa Anzai, Hatsue Ishibashi-Ueda, Kazunori Toyoda, Kazutaka Nishimura, Toshiyuki Uehara
Publikováno v:
Neurology and Clinical Neuroscience. 3:78-80
We describe herein the case of a 71-year-old man with the cardiac variant of Fabry disease presenting with cardioembolic stroke. Stroke is one of the most well-known manifestations of Fabry disease, and lacunar stroke is a widely recognized etiology.
Autor:
Yuya, Aotsuka, Akiyuki, Uzawa, Kazutaka, Nishimura, Kazuho, Kojima, Mika, Yamaguchi, Takahiro, Makino, Kazuo, Nakamichi, Masayuki, Saijo, Satoshi, Kuwabara
Publikováno v:
Internal medicine (Tokyo, Japan). 55(12)
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease that favors the cerebrum and typically occurs in immunosuppressed patients. We herein report the case of a 66-year-old man with PML, idiopathic CD4(+) T lymphocytopenia (ICL)